Wellbutrin
Smoking Cessation
Yale UniversityPhase 4 / ApprovedActive
A
82/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 74/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the Smoking Cessation cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Varenicline Tartrate University of California, San Diego | Phase 4 | A |
Naltrexone Yale University | Phase 4 | BBB |
Nicotine Rutgers, The State University of New Jersey | Phase 4 | BBB |
Tropisetron Baylor College of Medicine | Phase 3 | BB |
Risperdal Baylor College of Medicine | Phase 3 | BB |
View all 10 →
Same molecule, other indications
Wellbutrin is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →